In this study, we investigated the intricate relationship between psoriasis, obesity, and adipokines, with a focus on the influence of these last on disease severity and the response to anti-IL-17 and anti-IL-23 biologic therapies (19, 23). The gene discussed is IL17A; the disease is obesity due to melanocortin 4 receptor deficiency.